Dr Reddys Laboratories (RDY) Long-Term Investments (2012 - 2026)

Dr Reddys Laboratories' Long-Term Investments history runs 14 years deep, the most recent figure standing at $62.1 million for Q1 2026.

• In Q1 2026, Long-Term Investments fell 48.28% year-over-year to $62.1 million; the TTM figure through Mar 2026 stood at $62.1 million (down 48.28% YoY), while the FY2026 annual figure was $114.0 million, up 103.57% from the prior year.
• Long-Term Investments was $62.1 million for Q1 2026 at Dr Reddys Laboratories, down from $686.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $686.8 million in Q3 2025 to a low of -$3.8 million in Q3 2024.
• Historically, Long-Term Investments has averaged $253.9 million across 5 years, with a median of $91.0 million in 2026.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments tumbled 100.56% in 2024, then surged 18246.48% in 2025.
• A 5-year view of Long-Term Investments shows it stood at $231.8 million in 2022, then jumped by 193.55% to $680.4 million in 2023, then plunged by 100.56% to -$3.8 million in 2024, then soared by 18246.48% to $686.8 million in 2025, then plunged by 90.96% to $62.1 million in 2026.
• The last three Long-Term Investments figures came in at $62.1 million (Q1 2026), $686.8 million (Q3 2025), and -$595920.3 (Q2 2025), per Business Quant data.